MBL2 Polymorphism and Risk of Severe Infections in Multiple Myeloma Patients Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705466
Full Text
Open PDFAbstract
Available in full text
Date
September 4, 2006
Authors
Publisher
Springer Science and Business Media LLC